Rethinking factors affecting progression to CLTI following femoropopliteal endovascular revascularization in symptomatic PAD

Abstract

Get full access to this article

View all access options for this article.

References

Conte

Bradbury

Kolh

, et al Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 2019; 69: 3S–125S.e40.

Gornik

Aronow

Goodney

, et al 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2024; 149: e1313–e1410.

Sigvant

Lundin

Wahlberg

The risk of disease progression in peripheral arterial disease is higher than expected: A meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg 2016; 51: 395–403.

Shoji

Kitamura

Yoshida

, et al Risk factors for progression to chronic limb-threatening ischemia after endovascular therapy in patients with claudication. Vasc Med 2025; 30: 568–576.

Naiem

Doonan

Steinmetz

, et al Outcomes of endovascular treatment of patients with intermittent claudication due to femoropopliteal disease. Vascular 2022; 30: 882–890.

Froud

JLJ

Landin

Wafi

, et al Rate and predictors of disease progression in patients with conservatively managed intermittent claudication: A systematic review. Ann Vasc Surg 2025; 112: 183–192.